Navigation Links
Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology
Date:10/4/2010

dates. We cannot guarantee that we will be able to produce commercially successful products or maintain the commercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this news release related to our product candidates is preliminary and investigative. Such product candidates are not approved by the U.S. Food and

Drug Administration (FDA), and no conclusions can or should be drawn regarding the safety or effectiveness of the product candidates. Only the FDA can determine whether the product candidates are safe and effective for the use(s) being investigated. Further, the scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. FDA for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA can determine whether the products are safe and effective for these uses. Healthcare professionals should refer to and rely upon the FDA approved labeling for the products, and not the information discussed in this news release.CONTACT: AmgenAshleigh Koss: +1 (805) 313-6151 (U.S. media)Carrie Deverell: +41 41 3690 308 (E.U. media)Sabrina Paiva: +1 (905) 285-3145 (Canada media)Arvind Sood: +1 (805) 447-1060 (investors)(Logo:  http://photos.prnewswire.com/prnh/20081015/AMGE
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients
2. Positive SPA Reply From the FDA for TopoTargets Pivotal Trial With Belinostat in PTCL
3. Fifth DuraHeart(TM) U.S. Implant Marks Important Milestone in U.S. Pivotal Trial
4. Oncolytics Biotech Inc. Announces Decision to Pursue Phase II/III Pivotal Clinical Trial
5. Genmab A/S: Ofatumumab Pivotal CLL Data to be Presented at ASH
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Reaches Halfway Point
7. BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009
8. BioSyntech Achieves Enrolment Goal for Pivotal Trial of BST-CarGel(R), its Cartilage Repair Device
9. ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results
10. PROVENGE Significantly Prolongs Survival in Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
11. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015 A ... the NCATS rare-diseases portfolio " in Science ... new financing technique to reduce the risk associated ... and potentially unlock new levels of funding for ... product of a unique collaboration between scientists at ...
(Date:2/27/2015)... 2015 Immunovaccine Inc. (“Immunovaccine”) (TSX: ... today announced that the U.S. Food and Drug ... designation and Phase I clinical trials of the ... mutual co-development agreement signed with Gilead Life Sciences. ... for the DPX-Survivac. , “We have been in ...
(Date:2/27/2015)... , Feb. 27, 2015 Bionomics Limited ... the DisrupTOR-1 trial of BNC105 in patients with metastatic ... Orlando, Florida . The data will ... the City of Hope Comprehensive Cancer Center in ... The new data identifies Ferritin and IL-8 ...
(Date:2/27/2015)... 27, 2015 FamilyFarms Group is pleased ... of State Line Farms, received the 2015 Tomorrow’s Top ... under the age of 35, who has demonstrated excellence ... honor to win the Tomorrow's Top Producer Horizon Award. ... the Top Producer Award and learning from their experiences. ...
Breaking Biology Technology:New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2
... , , , , , , For fast and efficient multiplex ... , , , ... Storage and Stability , Technical Assistance ... Product Use Limitations , Product Warranty and Satisfaction Guarantee , ...
... , , , Fully automated sample preparation for clinical , ... , , ... for reliable results , , QIAsoft MDx ... Full process documentation and sample tracking for effortless data management , ...
... , , , The BioRobot MDx is the latest addition , ... of scientists requiring standardized protocols in environments such as clinical , ... , , ... , Standardized nucleic acid purification and reaction setup ...
Cached Biology Technology:QIAGEN Multiplex PCR Handbook 2QIAGEN Multiplex PCR Handbook 3QIAGEN Multiplex PCR Handbook 4QIAGEN Multiplex PCR Handbook 5QIAGEN Multiplex PCR Handbook 6QIAGEN Multiplex PCR Handbook 7QIAGEN Multiplex PCR Handbook 8QIAGEN Multiplex PCR Handbook 9QIAGEN Multiplex PCR Handbook 10QIAGEN Multiplex PCR Handbook 11QIAGEN Multiplex PCR Handbook 12QIAGEN Multiplex PCR Handbook 13QIAGEN Multiplex PCR Handbook 14QIAGEN Multiplex PCR Handbook 15QIAGEN Multiplex PCR Handbook 16QIAGEN Multiplex PCR Handbook 17QIAGEN Multiplex PCR Handbook 18QIAGEN Multiplex PCR Handbook 19QIAGEN Multiplex PCR Handbook 20QIAGEN Multiplex PCR Handbook 21QIAGEN Multiplex PCR Handbook 22QIAGEN Multiplex PCR Handbook 23QIAGEN Multiplex PCR Handbook 24QIAGEN Multiplex PCR Handbook 25QIAGEN Multiplex PCR Handbook 26QIAGEN Multiplex PCR Handbook 27QIAGEN Multiplex PCR Handbook 28QIAGEN Multiplex PCR Handbook 29QIAGEN Multiplex PCR Handbook 30QIAGEN Multiplex PCR Handbook 31QIAGEN Multiplex PCR Handbook 32QIAGEN Multiplex PCR Handbook 33BioRobot MDx Workstation 2BioRobot MDx standardize your automated protocols in clinical , laboratories 2BioRobot MDx standardize your automated protocols in clinical , laboratories 3
(Date:2/5/2015)... , Feb. 3, 2015 Despite a ... from industries such as consumer electronics, automotive, storage ... surface mount technology (SMT) screen printers. Innovations in ... control will push the adoption curve up. Meanwhile, ... steady as glue dispensers are indispensable in the ...
(Date:1/22/2015)... , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the leading source ... launch of its new website design. "When we ... infancy", says Peter O,Neill , founder and CEO of ... industry needs involvement from the key players on a very ...
(Date:1/22/2015)... Jan. 15, 2015  BellBrook Labs, a leader in ... the launch of a TR-FRET (time resolved Forster ... UDP Assay, a high throughput screening assay for ... will allow for sensitive detection of hundreds of ...
Breaking Biology News(10 mins):End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2
... Researchers in a multicenter international study have identified a new ... breast cancer by more than a third. Further, ... well-known breast cancer gene BRCA1. Alternations in either gene cause ... a path to breast cancer developing. This leads researchers to ...
... PHILADELPHIA - James Shorter, PhD, Assistant Professor of Biochemistry ... Medicine, has been named an inaugural recipient of the ... award totals $1.5 million in direct costs over five ... are in the early stages of their careers. More ...
... University of California, Irvine scientists have discovered how to ... most common form of mental impairment. Neurobiologist Julie ... linked to fragile X syndrome blocks brain cells from ... called fragile X mental retardation 1 (Fmr1) -- is ...
Cached Biology News:Researchers find new gene linked to breast cancer 2Researchers find new gene linked to breast cancer 3Penn biochemist receives NIH New Innovator's Award 2UCI researchers restore memory process in most common form of mental disability 2
... NAP-10 Columns, 50. For rapid and efficient ... in less than 15 minutes by gravity ... distilled water containing 0.15% Kathon CG/ICP Biocide.Available ... 0.5 ml (NAP-5), 1 ml (NAP-10) ...
Human ROR1 Affinity Purified Polyclonal Ab...
Human Rad1 MAb (Clone 33)...
Recombinant Ovine (Sheep) Growth Hormone, Ultra Pure...
Biology Products: